Synthetic cells as immunotherapeutics to remodel the tumour microenviroment
Diseases generate microenvironments with differing physical, chemical, and biological properties compared to healthy tissues. In cancer, the tumour microenvironment (TME) promotes progression and therapy resistance of the most advanced therapeutics including ‘smart’ nanomedicines and engineered cell-based therapies. While nanomedicines are limited in tunability of function, cell-based therapies can be engineered to modify their microenvironments (e.g….
